Schellenberg Wittmer has advised Emeram, a Munich-based investment manager focused on mid-sized companies in the German-speaking region, on its acquisition of a stake in Solar Manager AG, a Swiss developer of intelligent Home Energy Management
Tags :Beat Speck
Wenger Vieli advised the shareholders of Starmind, a Swiss provider of AI-based knowledge solutions, in connection with its sale to Capacity, a US-based enterprise AI company. The parties Founded in Zurich, Switzerland, Starmind has developed
Team.blue, a provider of AI-powered digital products and services for small and medium-sized busineseses, completed a strategic investment in Windsor Group, the operator of a Swiss AI-powered data integration and marketing attribution platform for
Wenger Vieli advised the shareholders of Tofwerk on the company’s sale to Bruker, resulting in Bruker consolidating its ownership in Tofwerk to 100%. Headquartered in Thun, Switzerland, Tofwerk is a specialist ultra-fast time-of-flight mass spectrometry
Wenger Vieli advised Hoerbiger, a globally active technology group, on all Swiss legal aspects in connection with the acquisition of PI. Headquartered in Karlsruhe, PI is a provider high-precision motion and positioning solutions for
Wenger Vieli advised Hoerbiger, a globally active technology group specialising in performance-defining components for several industries, in connection with the company’s acquisition of Karlsruhe-based PI, a high-precision motion and positioning solutions specialist. Pursuant to
Wenger Vieli advised vascular implants specialist Xeltis on its financing round, raising approximately EUR 50 million. The sum includes up to EUR 37.5 million from the European Investment Bank (EIB) and EUR 10 million from existing shareholders such
Swiss life science and biotech company Arcoris Bio completed a CHF 6.3m seed financing round. In connection with the operation, Wenger Vieli advised Arcoris Bio, while MLL Legal represented German biotech investment fund Ventura Ace
Wenger Vieli advised TRI Dental Implants, a Hünenberg-based provider of digital dental implant solutions, on a minority investment in the company by Swiss medtech specialist in medical regeneration Geistlich Pharma. The Wenger Vieli team
Wenger Vieli advised the shareholders of Swiss-based individualised rehabilitation specialist SKS Rehab in connection with its merger with Roltec El-Kørestole, leading to the formation of the new SKS Roltec Group. Moreover, the SKS Roltec
